Improving HLA matching for kidney transplantation by use of CREGs

Lancet

Volumn 355, Issue 9218, 2000, Pages 1842-1843

  McKenna, Rachel M ^a   Takemoto, Steven K ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIGEN; HLA ANTIGEN;

EUROPE; GRAFT REJECTION; HLA MATCHING; HUMAN; KIDNEY TRANSPLANTATION; NOTE; PRIORITY JOURNAL; UNITED STATES;

EID: 0034720637     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02283-2     Document Type: Note

References (12)

1. Morris P.J., Johnson R.J., Fuggle S.V., Belger M.A., Briggs J.D. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA). Lancet. 354:1999;1147-1152.
2. Hata Y., Cecka J.M., Takemoto S., Ozawa M., Cho Y.W., Terasaki P.I. Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients. Transplantation. 65:1998;208-212.
3. Sijpkens Y.W.J., Doxiadis I.I.N., de Fijter J.W.et al. Sharing cross-reactive groups of MHC class I improves long-term graft survival. Kidney Int. 56:1999;1920-1927.
4. Wujciak T., Opelz G. Evaluation of HLA matching for CREG antigens in Europe. Transplantation. 68:1999;1097-1099.
5. Fuller A.A., Rodey G.E., Parham P., Fuller T.C. Epitope map of the HLA B7 CREG using affinity-purified human alloantibody probes. Hum Immunol. 28:1990;306-325.
6. Konoeda Y., Terasaki P.I., Wakisaka A., Park M.S., Mickey M.R. Public determinants of HLA indicated by pregnancy antibodies. Transplantation. 41:1986;253-259.
7. Sanfilippo F., Vaughn W.K., Spees E.K., Heise E.R., LeFor W.M. The effect of HLA-A,-B matching on cadaver renal allograft rejection comparing public and private specificities. Transplantation. 38:1984;483-489.
8. Takemoto S., Terasaki P.I., Gjertson D.W., Cecka J.M. Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med. 331:1994;760-764.
9. Starzl T.E., Eliasziw M., Gjertson D.et al. HLA and cross-reactive antigen group matching for cadaver kidney allocation. Transplantation. 64:1997;983-991.
10. McKenna R.M., Lee K.R., Gough J.C.et al. Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function. Transplantation. 66:1998;38-43.
11. McKenna R.M., Takemoto S.K., Terasaki P.I. Anti-HLA antibodies after solid organ transplantation. Transplantation. 69:2000;319-326.
12. Fuller T.C., Fuller A. The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder. Transplantation. 68:1999;173-182.